Explosives Trace Detector Approved for Passenger and Baggage Screening
- Implant Sciences QS-B220 explosives trace detector approved for passenger and baggage screening at U.S. airports
Marking a major milestone for the Company, Implant Sciences, a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its QS-B220 desktop explosives trace detector has successfully completed the certification process for the United States Transportation Security Administration's (TSA) Explosive Trace Detection (ETD) qualification requirements for aviation checkpoint and checked baggage screening. The QS-B220 becomes the first ETD with a non-radioactive source to be added to the TSA's Qualified Product List (QPL).
"The addition of the QS-B220 to TSA's QPL is the single most significant achievement in our Company's history," stated Implant Sciences' President and CEO, Glenn D. Bolduc . "We're very proud to be able to deliver this innovative product for the protection of travelers in our country. Every member of the Implant Sciences team has done a phenomenal job of getting us to this point. We would also like to recognize the support we have received from our shareholders and other investors over the last few years while we have been pursuing this most significant qualification. Without their support this would not have been achievable."
A-Share Listed Airport and Shipping Companies - Profiles and Financial Data
"Being added to TSA's QPL is one of the highest levels of recognition in the security industry and one of the most difficult to achieve. The team at Implant Sciences has been nothing short of remarkable and focused in preparing the QS-B220 for this challenge," continued Todd Silvestri , VP of Technology for Implant Sciences Corporation. "Implant Sciences has highlighted their deep domain knowledge in the development and commercialization of this unit, and we are excited as a company to have cleared the last major hurdle in the U.S. aviation market."
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
Source : Implant Sciences Corporation - view original press release